In cancer, resistance and tolerance mechanisms play role as well as infections
3/28/2014
A Stanford University lab whose studies have advanced scientific understanding of resistance and tolerance defense mechanisms to bacterial and viral pathogens has now turned its sights on cancer.
Mood-stabilizing drug may reduce risk of developing head and neck cancer
3/28/2014
A new study indicates that a commonly used mood stabilizing drug may help prevent head and neck cancer. The study is published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
Nanotube coating helps shrink mass spectrometers
3/28/2014
Nanotechnology is advancing tools likened to Star Trek's "tricorder" that perform on-the-spot chemical analysis for a range of applications including medical testing, explosives detection and food safety.
In mouse model of breast cancer peaches inhibit metastasis
3/28/2014
Lab tests at Texas A&M AgriLife Research have shown that treatments with peach extract inhibit breast cancer metastasis in mice.AgriLife Research scientists say that the mixture of phenolic compounds present in the peach extract are responsible for the inhibition of metastasis, according to the study, which was this month published in the Journal of Nutritional Biochemistry.
MRI helps diagnose prostate cancer more accurately
3/27/2014
In a world first, an Australian clinical trial has shown that biopsy guided by MRI can significantly improve the diagnosis of life-threatening prostate cancer and reduce the over-diagnosis of non-life-threatening cases, thus avoiding the side effects of unnecessary treatment.
NICE rejects life-extending bowel cancer drug two weeks after Scottish approval
3/27/2014
NICE announced on 25 March 2014 that it is not recommending ZALTRAP® (aflibercept) to the NHS in England and Wales for the treatment of advanced, metastatic colorectal cancer (mCRC).1 Based on the same basic evidence, aflibercept was approved for use in Scotland on 10 March.
Researchers say gold-based drug shows promise for fighting bone cancer in people and pets
3/27/2014
A gold-based drug currently used in human and veterinary medicine to manage certain immune diseases may prove useful in combating osteosarcoma, a devastating bone cancer that affects both dogs and people, University of Florida veterinary researchers report.
Plasma tool for destroying cancer cells
3/27/2014
Inducing biological tissue damage with an atmospheric pressure plasma source could open the door to many applications in medicine.Plasma medicine is a new and rapidly developing area of medical technology. Specifically, understanding the interaction of so-called atmospheric pressure plasma jets with biological tissues could help to use them in medical practice.
Inducing biological tissue damage with plasma tool may destroy cancer cells
3/27/2014
Plasma medicine is a new and rapidly developing area of medical technology. Specifically, understanding the interaction of so-called atmospheric pressure plasma jets with biological tissues could help to use them in medical practice.
Financial decline due to breast cancer treatment reported by twenty-five percent of survivors
3/27/2014
Four years after being treated for breast cancer, a quarter of survivors say they are worse off financially, at least partly because of their treatment, according to a new study led by University of Michigan Comprehensive Cancer Center researchers.In addition, 12 percent reported that they still have medical debt from their treatment.